Atleva Specialistvård AB´s Gothenburg based clinics; HandCenter, FotCenter and Smärthjälpen will move in at GoCo in July 2023.

After 7 years situated in Gårda, our Gothenburg clinics have outgrown their costume and need more space. The clinics are moving in under one roof this summer together with, among others, Evidia röntgen and SynLab. The main entrance level have large areas with a warm and welcoming environment. Staffed reception, Evidia röntgen and SynLab, Smärthjälpen and our physiotherapy unit incl. a large gymnasium for various rehab activities.

One floor up is the operating theaters with waiting rooms, patient changing rooms, pre- and post-operative departments with associated sterile technology unit. The latest equipment to meet the requirements for implant and prosthetic surgery. Separate entry/exit from the outside for patients undergoing surgery.

Our HandCenter and FootCenter receptions with associated rehab are located on floor 2. We have a lot going on within the Atleva group. 2022 again opened up for development in the form of conferences, trainings and networking, which has really boosted the entire organization and moving in to GoCo will give us new opportunities. We continue to focus on; high quality, high competence; simplicity and digitization; new ways of working; visibility; resilience and sustainability. This as we want to develop and at the same time maintain what we have today.

Evidia provides radiology services in Sweden, Norway and Germany. Evidia Sweden is available in several locations from the north to the south. We perform in total more than 500 000 examinations a year. Examinations available in Evidia Sweden are MRI, computer tomography, X-ray, mammography, ultrasound and bone density measurement. At Evidias department in GoCo Mölndal MRI and x-ray examinations will be available.

Clinical Trial Consultants (CTC) is choosing GoCo Clinic to its 6th clinical trial units. CTC founded in 2011, is a Swedish full-service contract research organisation (CRO) with an internal Site Network Currently, CTC's Site Network consists of five state-of-the-art clinical research units located in Uppsala, Stockholm, and Linköping. With the establishment of the new clinic at GoCo Health Innovation City, CTC's Site Network will have a total of 60 beds for early clinical trials and will support the clinical conduct of studies in all phases of development as well as medical device investigations. CTC is moving in at GoCo Clinic in the fall of 2023 and the site will be equipped with the latest technology for conducting clinical trials, including 8 beds for early phase clinical trials and a high capacity for out-patient visits.

Ribocure Pharmaceuticals AB (Ribocure) is a newly established Swedish biotech company with a business focus on the development of cutting-edge RNA therapeutics. Our mission is to build a world-leading RNA therapeutics R&D company in Sweden and help patients all over the world.

Ribocure is primarily focusing on rare diseases within cardiovascular, renal and oncology therapeutic areas to address highly unmet medical needs. The company is devoted to discovery and development of first- and best-in-class drug assets building upon innovative oligonucleotide technologies. As a subsidiary of Ribo Life Science Co., Ltd., Ribocure is able to combine the strength of a vertically integrated oligonucleotide research platform, with its translational and clinical operational excellence within the company. Our technological platforms provide a full set of solution from sequence design, screening, optimization, delivery technologies, all the way to large scale commercial CMC capacity. In 2022 we were able to advance three projects into clinical stages with a current average time of 20-24 months from idea to man.

On the entire fifth floor of the GoCo Clinic building, Ribocure has established a unique “from bench-to-bed” set-up with an R&D department, a Ph2 clinical trial unit (CTU) and an in vitro human cell lab. The CTU is dedicated and specialized for high quality proof of principle/concept phase 1B and phase 2 trials within our clinical expertise areas including a functional imaging core lab capacity.

Ribocure will be expanding heavily in Sweden and looking for new talents to join, and academic associations as well as small and large enterprise partners to collaborate with, with the joint goal of developing highly differentiated and innovative oligonucleotide therapeutics to help patients in need.